United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 280,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "12193012-82fa-4e76-9932-107202eb66bc",
"title": "Meta in talks for scale AI investment that could top $10 billion",
"description": "Meta Platforms Inc. in talks for multibillion-dollar investment in Scale AI, a key player in AI data labeling services.",
"keywords": "Meta, Scale AI, multibillion-dollar investment, AI, Artificial Intelligence",
"snippet": "Meta Platforms Inc. is in talks to make a multibillion-dollar investment into artificial intelligence startup Scale AI, according to people familiar with the ma...",
"url": "https://www.thehindubusinessline.com/info-tech/meta-in-talks-for-scale-ai-investment-that-could-top-10-billion/article69670835.ece",
"image_url": "https://bl-i.thgim.com/public/incoming/q8sntz/article69670837.ece/alternates/LANDSCAPE_1200/2025-05-15T192852Z_505355435_RC29CCAWFIAI_RTRMADP_3_META-PLATFORMS-AI.JPG",
"language": "en",
"published_at": "2025-06-08T06:29:45.000000Z",
"source": "thehindubusinessline.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMZN",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 16.720245,
"sentiment_score": 0.3612,
"highlights": [
{
"highlight": "Meanwhile, Big Tech peers have invested [+259 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 9.748737,
"sentiment_score": 0.3612,
"highlights": [
{
"highlight": "Meanwhile, Big Tech peers have invested [+259 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 15.420616,
"sentiment_score": 0.3612,
"highlights": [
{
"highlight": "Meanwhile, Big Tech peers have invested [+259 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "META",
"name": "Meta Platforms Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 12.463629,
"sentiment_score": 0.6808,
"highlights": [
{
"highlight": "<em>Meta</em> <em>Platforms</em> <em>Inc[+300 characters]",
"sentiment": 0.6808,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "7da934fb-8bf5-41e5-8383-4c506e8fb2b4",
"title": "Top Banker Vows Loyalty to DEI at Tokyo Pride Parade as Trump’s Pushback Rages",
"description": "The head of one of Japan’s largest investment banks used the Tokyo Pride parade to strike a rare public stance on pushing ahead with diversity initiatives, as US President Donald Trump seeks to abolish such policies.",
"keywords": "diversity initiatives, Tokyo Pride parade, LGBTQ rights, anti-DEI policy, Japanese companies",
"snippet": "The head of one of Japan’s largest investment banks used the Tokyo Pride parade to strike a rare public stance on pushing ahead with diversity initiatives, as...",
"url": "https://www.livemint.com/companies/news/top-banker-vows-loyalty-to-dei-at-tokyo-pride-parade-as-trump-s-pushback-rages-11749363912832.html",
"image_url": "https://www.livemint.com/lm-img/img/2024/12/06/1600x900/company_2_1733465085102_1733465089141.png",
"language": "en",
"published_at": "2025-06-08T06:25:12.000000Z",
"source": "livemint.com",
"relevance_score": null,
"entities": [
{
"symbol": "C",
"name": "Citigroup Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 17.045849,
"sentiment_score": 0.2617,
"highlights": [
{
"highlight": "In response, <em>Citigroup</em> <em>Inc<[+314 characters]",
"sentiment": 0.2617,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SMFG",
"name": "Sumitomo Mitsui Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 46.32703,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Sumitomo</em> <em>Mitsui</em> <em>Fi[+265 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NMR",
"name": "Nomura Holdings, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 29.524837,
"sentiment_score": -0.1779,
"highlights": [
{
"highlight": "Major financial firms including <em>Nomu[+282 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DSEEY",
"name": "Daiwa Securities Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 33.33063,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "“Even if the US has adopted an anti-DE[+292 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SMFNF",
"name": "Sumitomo Mitsui Financial Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 46.326763,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Sumitomo</em> <em>Mitsui</em> <em>Fi[+265 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "f46125e4-d4c8-4421-ab39-b3762edd6c11",
"title": "Snowflake Stock: I'm Still Unconvinced (Technical Analysis, Upgrade) (NYSE:SNOW)",
"description": "Snowflake Q1 earnings were mixed, with revenue growth hitting multiyear lows and cash flows showing weakness. Check out why SNOW stock is a Hold.",
"keywords": "",
"snippet": "Snowflake Inc. (NYSE: SNOW ) has advanced around 35% since my sell rating back in early March, but I remain unconvinced by the company's fundamental setup. Stil...",
"url": "https://seekingalpha.com/article/4793225-snowflake-im-still-unconvinced-technical-analysis-upgrade",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1208108273/image_1208108273.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-08T06:24:13.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SNOW",
"name": "Snowflake Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 102.78972,
"sentiment_score": 0.1998,
"highlights": [
{
"highlight": "<em>Snowflake</em> <em>Inc</em>. (<em>NY[+316 characters]",
"sentiment": 0.7814,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Snowflake</em> Stock: I'm Still Unconvinced (Technical Analysis, Upgrade) (<em>NYSE:SNOW</em>)",
"sentiment": -0.3818,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "64d745a2-d51b-4b1f-8585-29ceb39d6560",
"title": "Altria Group: Big Issues Necessitate Caution (NYSE:MO)",
"description": "Altria management prioritizes buybacks and dividends over diversification, limiting long-term growth potential. See why caution is warranted for MO investors.",
"keywords": "",
"snippet": "Back in January of this year, one company that I decided to revisit was tobacco giant Altria Group (NYSE: MO ). In the past, I had been bullish about the compan...",
"url": "https://seekingalpha.com/article/4793224-altria-group-big-issues-necessitate-caution",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1217747083/image_1217747083.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-08T06:22:57.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MO",
"name": "Altria Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 103.87981,
"sentiment_score": 0.3071,
"highlights": [
{
"highlight": "Back in January of this year, one compan[+312 characters]",
"sentiment": 0.6142,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Altria</em> Group: Big Issues Necessitate Caution (<em>NYSE:MO</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "6e5574ff-36f2-4ea5-87be-eab96c7d9210",
"title": "Range Resources: A Low-Cost LNG Lever On The Tightening U.S. Gas Market (NYSE:RRC)",
"description": "Range Resources operates efficiently with a low-cost drilling model. Read what makes RRC stock a compelling long-term investment for natural gas exposure.",
"keywords": "",
"snippet": "Range Resources (NYSE: RRC ) is a leading natural gas producer with its core operations in the Marcellus Shale in Appalachia . Its key advantage lies in its ult...",
"url": "https://seekingalpha.com/article/4793217-range-resources-a-low-cost-lng-lever-on-the-tightening-us-gas-market",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2156739559/image_2156739559.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-08T05:12:54.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "RRC",
"name": "Range Resources Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 105.5261,
"sentiment_score": 0.3062,
"highlights": [
{
"highlight": "<em>Range</em> <em>Resources</em> (<em>N[+305 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Range</em> <em>Resources</em>: A Low-Cost LNG Lever On The Tightening U.S. Gas Market (<em>NYSE:RRC</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "9d8497e1-1de8-4ef8-9bd4-411cb3c7e7d8",
"title": "Hyundai, Maruti Suzuki expect robust growth in export volumes in FY26",
"description": "Hyundai and Maruti Suzuki anticipate single-digit and 20% growth in exports, respectively, amid challenging domestic market conditions.",
"keywords": "",
"snippet": "Maruti Suzuki and Hyundai Motor India expect healthy growth in overseas shipments in the current fiscal year amid challenging business environment in the domest...",
"url": "https://www.thehindubusinessline.com/companies/hyundai-maruti-suzuki-expect-robust-growth-in-export-volumes-in-fy26/article69670751.ece",
"image_url": "https://bl-i.thgim.com/public/incoming/rz64uz/article69670758.ece/alternates/LANDSCAPE_1200/2024-10-17T124533Z_889914829_RC2PFAAVSACZ_RTRMADP_3_HYUNDAI-INDIA-IPO.JPG",
"language": "en",
"published_at": "2025-06-08T05:11:57.000000Z",
"source": "thehindubusinessline.com",
"relevance_score": null,
"entities": [
{
"symbol": "SZKMY",
"name": "Suzuki Motor Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 29.729204,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "Last month, <em>Suzuki</em> <em>Motor</e[+267 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SZKMF",
"name": "Suzuki Motor Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 29.729168,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "Last month, <em>Suzuki</em> <em>Motor</e[+267 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4c9be16e-e343-4a3f-90c5-f3182f714fb3",
"title": "PlayStation 5 to be around 'for a while' before PS 6 is released",
"description": "Sony's PlayStation 5, a massive success with nearly 75 million units sold despite global challenges, will continue its run alongside newer consoles. Hideaki Nishino, a Sony executive, assures fans that the PS5, like the PS4, has a long lifespan ahead. Sony aims to balance long-lasting hardware with technological advancements, introducing innovations while supporting existing consoles.",
"keywords": "PlayStation 5, PS5 sales, PS 5, PS5 Slim, PS4 longevity, PS5 Pro, Sony gaming console, Sony Interactive Entertainment, gaming technology advancements, upcoming PS6 release",
"snippet": "PS5 will be around, just like the PS4: Sony executive\n\nLive Events\n\n\n\n\n\n(You can now subscribe to our\n\n(You can now subscribe to our Economic Times WhatsApp cha...",
"url": "https://economictimes.indiatimes.com/news/new-updates/playstation-5-to-be-around-for-a-while-before-ps-6-is-released/articleshow/121703746.cms",
"image_url": "https://img.etimg.com/thumb/msid-121703790,width-1200,height-630,imgsize-8410,overlay-economictimes/articleshow.jpg",
"language": "en",
"published_at": "2025-06-08T05:03:13.000000Z",
"source": "economictimes.indiatimes.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 19.617485,
"sentiment_score": 0.77,
"highlights": [
{
"highlight": "PS5 will be around, just like the PS4: <[+211 characters]",
"sentiment": 0.7624,
"highlighted_in": "main_text"
},
{
"highlight": "The PS 5 has survived the global chip sh[+319 characters]",
"sentiment": 0.7693,
"highlighted_in": "main_text"
},
{
"highlight": "the future of PS 5 is uncertain.Last yea[+174 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "24705171-48c8-4529-8b32-15fce38f9516",
"title": "Regeneron Pharmaceuticals Inc (REGN) Announces Promising Results from Dupixent Trial in Atopic Dermatitis for Skin of Color | REGN stock news",
"description": "Summary Regeneron Pharmaceuticals Inc (REGN) and Sanofi have released results from their DISCOVER Phase 4 trial, showcasing the efficacy of Dupixent® (dupiluma",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Summary\n\nRegeneron Pharmaceuticals Inc (REGN, Financial) and Sanofi have released results from their DISCOVER Phase 4 trial, showcasing the efficacy of Dupixent...",
"url": "https://www.gurufocus.com/news/2914378/regeneron-pharmaceuticals-inc-regn-announces-promising-results-from-dupixent-trial-in-atopic-dermatitis-for-skin-of-color-regn-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-08T05:00:57.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 100.59807,
"sentiment_score": 0.319767,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+242 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+242 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Results from Dupixent Trial in Atopic Dermatitis for Skin of Color | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "0b22af68-547e-42eb-8dba-7f4bd581ffa6",
"title": "Regeneron Pharmaceuticals Inc (REGN) Announces Promising Results from Dupixent Trial in Patients with Skin of Color | REGN stock news",
"description": "Summary Regeneron Pharmaceuticals Inc (REGN) and Sanofi have released results from their DISCOVER Phase 4 trial, which evaluated Dupixent® (dupilumab) in patie",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Summary\n\nRegeneron Pharmaceuticals Inc (REGN, Financial) and Sanofi have released results from their DISCOVER Phase 4 trial, which evaluated Dupixent® (dupilum...",
"url": "https://www.gurufocus.com/news/2914284/regeneron-pharmaceuticals-inc-regn-announces-promising-results-from-dupixent-trial-in-patients-with-skin-of-color-regn-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-08T00:00:49.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.29045,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+223 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Results from Dupixent Trial in Patients with Skin of Color | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.292465,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+223 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Results from Dupixent Trial in Patients with Skin of Color | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 103.29006,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+223 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Results from Dupixent Trial in Patients with Skin of Color | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 103.28879,
"sentiment_score": 0.20095,
"highlights": [
{
"highlight": "Summary\n\n<em>Regeneron</em> <em>Pharmace[+223 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</em> <em>Inc</em> (REGN) Announces Promising Results from Dupixent Trial in Patients with Skin of Color | REGN stock news",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "458c3796-f636-4031-a1da-58d4f83a12f7",
"title": "Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color",
"description": "Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall disease sev",
"keywords": "GuruFocus, Article, News, Marketwired, REGN",
"snippet": "Atopic dermatitis is a chronic disease that disproportionately impacts communities of color\n\nDupixent achieved 75% or greater improvement in overall disease sev...",
"url": "https://www.gurufocus.com/news/2914283/dupixent-dupilumab-data-at-revolutionizing-atopic-dermatitis-rad-conference-reinforce-use-in-atopic-dermatitis-patients-with-skin-of-color",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-08T00:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.616196,
"sentiment_score": 0.04615,
"highlights": [
{
"highlight": "disease severity, the primary endpoint, [+333 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+219 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Regeneron Forward-Looking Statements and[+229 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and other information about Re[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.616974,
"sentiment_score": 0.04615,
"highlights": [
{
"highlight": "disease severity, the primary endpoint, [+333 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+219 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Regeneron Forward-Looking Statements and[+229 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and other information about Re[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 17.61672,
"sentiment_score": 0.04615,
"highlights": [
{
"highlight": "disease severity, the primary endpoint, [+333 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+219 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Regeneron Forward-Looking Statements and[+229 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and other information about Re[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.616749,
"sentiment_score": 0.04615,
"highlights": [
{
"highlight": "disease severity, the primary endpoint, [+333 characters]",
"sentiment": 0.7269,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharmaceuticals</em>, <em>Inc</em>. [+219 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Regeneron Forward-Looking Statements and[+229 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and other information about Re[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "1309db74-7a34-4d2d-9a21-a0c1b98f97fa",
"title": "Dupixent® (dupilumab) Data at Revolutionizing Atopic Dermatitis (RAD) Conference Reinforce Use in Atopic Dermatitis Patients with Skin of Color | REGN Stock News",
"description": "Regeneron (REGN) and Sanofi presented positive Phase 4 trial results for Dupixent® in treating atopic dermatitis in patients with skin of color. 76% of",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Regeneron (REGN, Financial) and Sanofi presented positive Phase 4 trial results for Dupixent® in treating atopic dermatitis in patients with skin of color.\n\n76...",
"url": "https://www.gurufocus.com/news/2914282/dupixent-dupilumab-data-at-revolutionizing-atopic-dermatitis-rad-conference-reinforce-use-in-atopic-dermatitis-patients-with-skin-of-color-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-06-07T23:45:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.38009,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+196 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.380077,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+196 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 42.37803,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+196 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 42.377266,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+196 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "5b3b7714-1c4d-4683-ace3-d713689714d3",
"title": "OppFi: Undervalued, Underrated Fintech With Unconventional Upside (NYSE:OPFI)",
"description": "OppFi's AI-driven, tech-enabled lending platform delivers strong growth and profitability. See why I rate OPFI stock a buy for long-term growth.",
"keywords": "",
"snippet": "Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions ...",
"url": "https://seekingalpha.com/article/4793215-oppfi-undervalued-underrated-fintech-with-unconventional-upside",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2170497017/image_2170497017.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-08T04:57:15.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "OPFI",
"name": "OppFi Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 91.35504,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>OppFi</em>: Undervalued, Underrated Fintech With Unconventional Upside (<em>NYSE:OPFI</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "36d07fa1-cc5c-47e3-8993-1aa700e8670e",
"title": "The Poco F7 Teaser Is Here, And It Might Be the Best Budget Flagship of 2025",
"description": "A sleek render of the Redmi Turbo 3, annotated with specs like Snapdragon 8s Gen 3, 1.5K AMOLED, and June 2025 Launch? If there’s one thing Poco knows how to do, it’s build hype. With the Poco F7…",
"keywords": "",
"snippet": "The Poco F7 Teaser Is Here, And It Might Be the Best Budget Flagship of 2025 Mahendra Shah Follow 2 min read · Just now Just now -- Listen Share\n\nWe are expect...",
"url": "https://medium.com/@bright.mahen/the-poco-f7-teaser-is-here-and-it-might-be-the-best-budget-flagship-of-2025-0390ca9a51b7",
"image_url": "https://miro.medium.com/v2/resize:fit:1200/1*3qpjeK2KNmgO4qhPJOUtWQ.jpeg",
"language": "en",
"published_at": "2025-06-08T04:32:32.000000Z",
"source": "medium.com",
"relevance_score": null,
"entities": [
{
"symbol": "SONY",
"name": "Sony Group Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 13.920388,
"sentiment_score": 0.0644,
"highlights": [
{
"highlight": "Poco F7 Expected Specs:\n\nChipset: Snapdr[+309 characters]",
"sentiment": 0.0644,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 426,
"sentiment_avg": 0.3161812952840601
}
]
}
Other details
Entity count
- 32,649